Chemoinformaics analysis of De-O-methyllasiodiplodin
| Molecular Weight | 278.348 | nRot | 0 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 18 |
| Exact Molecular Weight | 278.152 | nRing | 2 |
| Solubility: LogS | -3.517 | nHRing | 1 |
| Solubility: LogP | 4.625 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 44.5974 |
| nHD | 2 | BPOL | 24.6746 |
| QED | 0.712 |
| Synth | 3.199 |
| Natural Product Likeliness | 1.485 |
| NR-PPAR-gamma | 0.966 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.809 |
| MDCK | 0.0000317 |
| BBB | 0.365 |
| PPB | 0.976003 |
| VDSS | 0.634 |
| FU | 0.0215697 |
| CYP1A2-inh | 0.962 |
| CYP1A2-sub | 0.349 |
| CYP2c19-inh | 0.842 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.576 |
| CYP2c9-sub | 0.959 |
| CYP2d6-inh | 0.928 |
| CYP2d6-sub | 0.542 |
| CYP3a4-inh | 0.5 |
| CYP3a4-sub | 0.096 |
| CL | 9.838 |
| T12 | 0.728 |
| hERG | 0.02 |
| Ames | 0.067 |
| ROA | 0.028 |
| SkinSen | 0.877 |
| Carcinogencity | 0.085 |
| EI | 0.935 |
| Respiratory | 0.539 |
| NR-Aromatase | 0.473 |
| Antiviral | Yes |
| Prediction | 0.57534 |